Epstein–Barr Virus: Overcoming the DNA Damage Response

References

• Al-Hakim A , Escribano-DiazC, LandryMCet al. The ubiquitous role of ubiquitin in the DNA damage response. DNA Repair (Amst.), 9(12), 1229–1240 (2010).
   PubMed Web of Science ®Google Scholar
• Schwertman P , Bekker-JensenS, MailandN. Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers. Nat. Rev. Mol. Cell Biol., 17(6), 379–394 (2016).
   PubMed Web of Science ®Google Scholar
• Hollingworth R , GrandRJ. Modulation of DNA damage and repair pathways by human tumour viruses. Viruses, 7(5), 2542–2591 (2015).
   PubMed Web of Science ®Google Scholar
• Turnell AS , GrandRJ. DNA viruses and the cellular DNA-damage response. J. Gen. Virol., 93(Pt 10), 2076–2097 (2012).
   PubMedGoogle Scholar
• Mcfadden K , LuftigMA. Interplay between DNA tumor viruses and the host DNA damage response. Curr. Top. Microbiol. Immunol., 371, 229–257 (2013).
   PubMed Web of Science ®Google Scholar
• Pancholi NJ , PriceAM, WeitzmanMD. Take your PIKK: tumour viruses and DNA damage response pathways. Philos. Trans. R Soc. Lond. B Biol. Sci., 372(1732), (2017).
   PubMed Web of Science ®Google Scholar
• Hau PM , TsaoSW. Epstein–Barr virus hijacks DNA damage response transducers to orchestrate its life cycle. Viruses, 9(11), 652–668 (2017).
   Web of Science ®Google Scholar
• Dybas JM , HerrmannC, WeitzmanMD. Ubiquitination at the interface of tumor viruses and DNA damage responses. Curr. Opin. Virol., 32, 40–47 (2018).
   PubMed Web of Science ®Google Scholar
• Nikitin PA , YanCM, ForteEet al. An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein–Barr virus transformation of primary human B cells. Cell Host Microbe, 8(6), 510–522 (2010).
   PubMed Web of Science ®Google Scholar
• Nikitin PA , LuftigMA. The DNA damage response in viral-induced cellular transformation. Br. J. Cancer, 106(3), 429–435 (2012).
   PubMed Web of Science ®Google Scholar
• Jha HC , ShuklaSK, LuJ, AjMP, BanerjeeS, RobertsonES. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation. Oncotarget, 6(30), 30115–30129 (2015).
   PubMedGoogle Scholar
• Jha HC , AjMP, SahaA, BanerjeeS, LuJ, RobertsonES. Epstein–Barr virus essential antigen EBNA3C attenuates H2AX expression. J. Virol., 88(7), 3776–3788 (2014).
   PubMed Web of Science ®Google Scholar
• Hafez AY , MessingerJE, McFaddenKet al. Limited nucleotide pools restrict Epstein–Barr virus-mediated B-cell immortalization. Oncogenesis, 6(6), e349 (2017).
   PubMedGoogle Scholar
• Mordasini V , UedaS, AslandogmusRet al. Activation of ATR-Chk1 pathway facilitates EBV-mediated transformation of primary tonsillar B-cells. Oncotarget, 8(4), 6461–6474 (2017).
   PubMedGoogle Scholar
• Thorley-Lawson DA . EBV persistence – introducing the virus. Curr. Top. Microbiol. Immunol., 390(Pt 1), 151–209 (2015).
   PubMedGoogle Scholar
• Temple RM , ZhuJ, BudgeonL, ChristensenND, MeyersC, SampleCE. Efficient replication of Epstein–Barr virus in stratified epithelium in vitro..Proc. Natl Acad. Sci. USA, 111(46), 16544–16549 (2014).
   PubMed Web of Science ®Google Scholar
• Raab-Traub N . Nasopharyngeal carcinoma: an evolving role for the Epstein–Barr virus. Curr. Top. Microbiol. Immunol., 390(Pt 1), 339–363 (2015).
   PubMedGoogle Scholar
• Fukayama M . Epstein–Barr virus and gastric carcinoma. Pathol. Int., 60(5), 337–350 (2010).
   PubMed Web of Science ®Google Scholar
• Morales-Sanchez A , Fuentes-PananaEM. Epstein–Barr virus-associated gastric cancer and potential mechanisms of oncogenesis. Curr. Cancer Drug Targets, 17(6), 534–554 (2017).
   PubMed Web of Science ®Google Scholar
• Skalsky RL , CullenBR. EBV Noncoding RNAs. Curr. Top. Microbiol. Immunol., 391, 181–217 (2015).
   PubMed Web of Science ®Google Scholar
• Wang Y , GuoZ, ShuY, ZhouH, WangH, ZhangW. BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma. Eur. J. Cancer Prev., 26(2), 144–150 (2017).
   PubMed Web of Science ®Google Scholar
• Bose S , YapLF, FungMet al. The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma. J. Pathol., 217(3), 345–352 (2009).
   PubMed Web of Science ®Google Scholar
• Lung RW , HauPM, YuKHet al. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma. J. Pathol., 244(4), 394–407 (2018).
   PubMed Web of Science ®Google Scholar
• Zheng X , WangJ, WeiLet al. Epstein–Barr virus microRNA miR-BART5-3p inhibits p53 expression. J. Virol., 92(23), (2018).
   Web of Science ®Google Scholar
• Wang LW , JiangS, GewurzBE. Epstein–Barr virus LMP1-mediated oncogenicity. J. Virol., 91(21), (2017).
   Web of Science ®Google Scholar
• Starczynski J , SimmonsW, FlavellJRet al. Variations in ATM protein expression during normal lymphoid differentiation and among B-cell-derived neoplasias. Am. J. Pathol., 163(2), 423–432 (2003).
   PubMed Web of Science ®Google Scholar
• Dutton A , WoodmanCB, ChukwumaMBet al. Bmi-1 is induced by the Epstein–Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells. Blood, 109(6), 2597–2603 (2007).
   PubMed Web of Science ®Google Scholar
• Gruhne B , SompallaeR, MasucciMG. Three Epstein–Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene, 28(45), 3997–4008 (2009).
   PubMed Web of Science ®Google Scholar
• Ma X , YangL, XiaoLet al. Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-kappaB regulated ATM expression. PLoS ONE, 6(11), e24647 (2011).
   PubMed Web of Science ®Google Scholar
• Wasil LR , WeiL, ChangC, LanL, ShairKH. Regulation of DNA damage signaling and cell death responses by Epstein–Barr virus latent membrane protein 1 (LMP1) and LMP2A in nasopharyngeal carcinoma cells. J. Virol., 89(15), 7612–7624 (2015).
   PubMed Web of Science ®Google Scholar
• Lu J , TangM, LiHet al. EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma. Cancer Lett., 380(1), 191–200 (2016).
   PubMed Web of Science ®Google Scholar
• Frappier L . EBNA1 and host factors in Epstein–Barr virus latent DNA replication. Curr. Opin. Virol., 2(6), 733–739 (2012).
   PubMed Web of Science ®Google Scholar
• Frappier L . The Epstein–Barr virus EBNA1 protein. Scientifica (Cairo), 2012, 438204 (2012).
   PubMedGoogle Scholar
• Frappier L . Contributions of Epstein–Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival. Viruses, 4(9), 1537–1547 (2012).
   PubMed Web of Science ®Google Scholar
• Lassoued S , BenAmeur R, AyadiW, GargouriB, BenMansour R, AttiaH. Epstein–Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. Mol. Cell Biochem., 313(1–2), 179–186 (2008).
   PubMed Web of Science ®Google Scholar
• Cerimele F , BattleT, LynchRet al. Reactive oxygen signaling and MAPK activation distinguish Epstein–Barr virus (EBV)-positive versus EBV-negative Burkitt’s lymphoma. Proc. Natl Acad. Sci. USA, 102(1), 175–179 (2005).
   PubMed Web of Science ®Google Scholar
• Gruhne B , SompallaeR, MarescottiD, KamranvarSA, GastaldelloS, MasucciMG. The Epstein–Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc. Natl Acad. Sci. USA, 106(7), 2313–2318 (2009).
   PubMed Web of Science ®Google Scholar
• Kamranvar SA , MasucciMG. The Epstein–Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress. Leukemia, 25(6), 1017–1025 (2011).
   PubMed Web of Science ®Google Scholar
• Cao JY , MansouriS, FrappierL. Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein–Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses. J. Virol., 86, 382–394 (2011).
   PubMed Web of Science ®Google Scholar
• Sharpless NE , DepinhoRA. p53: good cop/bad cop. Cell, 110(1), 9–12 (2002).
   PubMed Web of Science ®Google Scholar
• Tavana O , GuW. Modulation of the p53/MDM2 interplay by HAUSP inhibitors. J. Mol. Cell Biol., 9(1), 45–52 (2017).
   PubMed Web of Science ®Google Scholar
• Li M , ChenD, ShilohAet al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature, 416(6881), 648–653 (2002).
   PubMed Web of Science ®Google Scholar
• Li M , BrooksCL, KonN, GuW. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell, 13(6), 879–886 (2004).
   PubMed Web of Science ®Google Scholar
• Cummins JM , RagoC, KohliM, KinzlerKW, LengauerC, VogelsteinB. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature, 428, 486–487 (2004).
   PubMed Web of Science ®Google Scholar
• Saridakis V , ShengY, SarkariFet al. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein–Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol. Cell, 18(1), 25–36 (2005).
   PubMed Web of Science ®Google Scholar
• Sheng Y , SaridakisV, SarkariFet al. Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nat. Struct. Mol. Biol., 13(3), 285–291 (2006).
   PubMed Web of Science ®Google Scholar
• Holowaty MN , ShengY, NguyenT, ArrowsmithC, FrappierL. Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP. J. Biol. Chem., 278(48), 47753–47761 (2003).
   PubMed Web of Science ®Google Scholar
• Holowaty MN , ZeghoufM, WuHet al. Protein profiling with Epstein–Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J. Biol. Chem., 278(32), 29987–29994 (2003).
   PubMed Web of Science ®Google Scholar
• Sivachandran N , SarkariF, FrappierL. Epstein–Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog., 4(10), e1000170 (2008).
   PubMed Web of Science ®Google Scholar
• Sivachandran N , DawsonCW, YoungLS, LiuFF, MiddeldorpJ, FrappierL. Contributions of the Epstein–Barr virus EBNA1 protein to gastric carcinoma. J. Virol., 86(1), 60–68 (2012).
   PubMed Web of Science ®Google Scholar
• Cheng TC , HsiehSS, HsuWL, ChenYF, HoHH, SheuLF. Expression of Epstein–Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity. Int. J. Oncol., 36(1), 151–160 (2010).
   PubMed Web of Science ®Google Scholar
• Pearson M , CarboneR, SebastianiCet al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature, 406(6792), 207–210 (2000).
   PubMed Web of Science ®Google Scholar
• Guo A , SalomoniP, LuoJet al. The function of PML in p53-dependent apoptosis. Nat. Cell Biol., 2(10), 730–736 (2000).
   PubMed Web of Science ®Google Scholar
• Sivachandran N , CaoJY, FrappierL. Epstein–Barr virus nuclear antigen 1 hijacks the host kinase CK2 to disrupt PML nuclear bodies. J. Virol., 84(21), 11113–11123 (2010).
   PubMed Web of Science ®Google Scholar
• Su D , MaS, ShanLet al. Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis. J. Clin. Invest., 128(10), 4280–4296 (2018).
   PubMed Web of Science ®Google Scholar
• Zhu Q , SharmaN, HeJ, WaniG, WaniAA. USP7 deubiquitinase promotes ubiquitin-dependent DNA damage signaling by stabilizing RNF168. Cell Cycle, 14(9), 1413–1425 (2015).
   PubMed Web of Science ®Google Scholar
• Zlatanou A , SabbionedaS, MillerESet al. USP7 is essential for maintaining Rad18 stability and DNA damage tolerance. Oncogene, 35(8), 965–976 (2015).
   PubMed Web of Science ®Google Scholar
• Dar A , ShibataE, DuttaA. Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway. Mol. Cell Biol., 33(16), 3309–3320 (2013).
   PubMed Web of Science ®Google Scholar
• Styles CT , PaschosK, WhiteRE, FarrellPJ. The cooperative functions of the EBNA3 proteins are central to EBV persistence and latency. Pathogens, 7(1), (2018).
   PubMed Web of Science ®Google Scholar
• Choudhuri T , VermaSC, LanK, MurakamiM, RobertsonES. The ATM/ATR signaling effector Chk2 is targeted by Epstein–Barr virus nuclear antigen 3C to release the G2/M cell cycle block. J. Virol., 81(12), 6718–6730 (2007).
   PubMed Web of Science ®Google Scholar
• Yi F , SahaA, MurakamiMet al. Epstein–Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. Virology, 388(2), 236–247 (2009).
   PubMed Web of Science ®Google Scholar
• Saha A , MurakamiM, KumarP, BajajB, SimsK, RobertsonES. Epstein–Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2. J. Virol., 83(9), 4652–4669 (2009).
   PubMed Web of Science ®Google Scholar
• Jha HC , YangK, El-NaccacheDW, SunZ, RobertsonES. EBNA3C regulates p53 through induction of Aurora kinase B. Oncotarget, 6(8), 5788–5803 (2015).
   PubMedGoogle Scholar
• Kudoh A , FujitaM, ZhangLet al. Epstein–Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J. Biol. Chem., 280(9), 8156–8163 (2005).
   PubMed Web of Science ®Google Scholar
• Kudoh A , IwahoriS, SatoYet al. Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in Epstein–Barr virus replication compartments. J. Virol., 83(13), 6641–6651 (2009).
   PubMed Web of Science ®Google Scholar
• Hau PM , DengW, JiaLet al. Role of ATM in the formation of the replication compartment during lytic replication of Epstein–Barr virus in nasopharyngeal epithelial cells. J. Virol., 89(1), 652–668 (2015).
   PubMed Web of Science ®Google Scholar
• Hagemeier SR , BarlowEA, MengQ, KenneySC. The cellular ataxia telangiectasia-mutated kinase promotes Epstein–Barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli. J. Virol., 86(24), 13360–13370 (2012).
   PubMed Web of Science ®Google Scholar
• Wang’ondu R , TealS, ParkR, HestonL, DelecluseH, MillerG. DNA damage signaling is induced in the absence of Epstein–Barr virus (EBV) lytic DNA replication and in response to expression of ZEBRA. PLoS ONE, 10(5), e0126088 (2015).
   PubMed Web of Science ®Google Scholar
• Bailey SG , VerrallE, SchelcherC, RhieA, DohertyAJ, SinclairAJ. Functional interaction between Epstein–Barr virus replication protein Zta and host DNA damage response protein 53BP1. J. Virol., 83(21), 11116–11122 (2009).
   PubMed Web of Science ®Google Scholar
• Huang SY , WuCC, ChengYJet al. Epstein–Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells. Oncotarget, 8(45), 78948–78964 (2017).
   PubMedGoogle Scholar
• Chiu SH , WuCC, FangCYet al. Epstein–Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma. Oncotarget, 5(18), 8583–8601 (2014).
   PubMedGoogle Scholar
• Wu CC , LiuMT, ChangYTet al. Epstein–Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells. Nucleic Acids Res., 38(6), 1932–1949 (2010).
   PubMed Web of Science ®Google Scholar
• Chang YH , LeeCP, SuMTet al. Epstein–Barr virus BGLF4 kinase retards cellular S-phase progression and induces chromosomal abnormality. PLoS ONE, 7(6), e39217 (2012).
   PubMed Web of Science ®Google Scholar
• Tarakanova VL , Leung-PinedaV, HwangSet al. γ-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe, 1(4), 275–286 (2007).
   PubMed Web of Science ®Google Scholar
• Li R , ZhuJ, XieZet al. Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe, 10(4), 390–400 (2011).
   PubMed Web of Science ®Google Scholar
• Li R , LiaoG, NirujogiRSet al. Phosphoproteomic profiling reveals Epstein–Barr virus protein kinase integration of DNA damage response and mitotic signaling. PLoS Pathog., 11(12), e1005346 (2015).
   PubMed Web of Science ®Google Scholar
• Ho TH , SitzJ, ShenQet al. A screen for Epstein–Barr virus proteins that inhibit the DNA damage response reveals a novel histone binding protein. J. Virol., 92(14), (2018).
   Web of Science ®Google Scholar
• Yang J , DengW, HauPMet al. Epstein–Barr virus BZLF1 protein impairs accumulation of host DNA damage proteins at damage sites in response to DNA damage. Lab. Invest., 95(8), 937–950 (2015).
   PubMed Web of Science ®Google Scholar
• Sato Y , KamuraT, ShirataNet al. Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex. PLoS Pathog., 5(7), e1000530 (2009).
   PubMed Web of Science ®Google Scholar
• Leung JW , AgarwalP, CannyMDet al. Nucleosome acidic patch promotes RNF168- and RING1B/BMI1-dependent H2AX and H2A ubiquitination and DNA damage signaling. PLoS Genet., 10(3), e1004178 (2014).
   PubMed Web of Science ®Google Scholar
• Mattiroli F , VissersJH, Van DijkWJet al. RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling. Cell, 150(6), 1182–1195 (2012).
   PubMed Web of Science ®Google Scholar
• Mattiroli F , UckelmannM, SahtoeDD, Van DijkWJ, SixmaTK. The nucleosome acidic patch plays a critical role in RNF168-dependent ubiquitination of histone H2A. Nat. Commun., 5, 3291 (2014).
   PubMed Web of Science ®Google Scholar
• Avgousti DC , DellaFera AN, OtterCJ, HerrmannC, PancholiNJ, WeitzmanMD. Adenovirus core protein VII down-regulates the DNA damage response on the host genome. J. Virol., 91(20), (2017).
   PubMed Web of Science ®Google Scholar
• Avgousti DC , HerrmannC, KulejKet al. A core viral protein binds host nucleosomes to sequester immune danger signals. Nature, 535(7610), 173–177 (2016).
   PubMed Web of Science ®Google Scholar
• Barbera AJ , ChodaparambilJV, Kelley-ClarkeBet al. The nucleosomal surface as a docking station for Kaposi’s sarcoma herpesvirus LANA. Science, 311(5762), 856–861 (2006).
   PubMed Web of Science ®Google Scholar
• Borozan I , ZapatkaM, FrappierL, FerrettiV. Analysis of Epstein–Barr virus genomes and expression profiles in gastric adenocarcinoma. J. Virol., 92(2), e01239–01317 (2018).
   PubMed Web of Science ®Google Scholar
• Cheng AZ , Yockteng-MelgarJ, JarvisMCet al. Epstein–Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity. Nat. Microbiol., 4(1), 78–88 (2019).
   PubMed Web of Science ®Google Scholar
• Harris RS , DudleyJP. APOBECs and virus restriction. Virology, 479–480, 131–145 (2015).
   PubMed Web of Science ®Google Scholar
• Strebel K . HIV accessory proteins versus host restriction factors. Curr. Opin. Virol., 3(6), 692–699 (2013).
   PubMed Web of Science ®Google Scholar
• Tatfi M , HermineO, SuarezF. Epstein–Barr virus (EBV)-related lymphoproliferative disorders in ataxia telangiectasia: does ATM regulate EBV life cycle?Front. Immunol., 9, 3060 (2018).
   PubMed Web of Science ®Google Scholar
• Hu L , LinZ, WuYet al. Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing. Front. Med., 10(1), 61–75 (2016).
   PubMed Web of Science ®Google Scholar
• Abate F , AmbrosioMR, MundoLet al. Distinct viral and mutational spectrum of endemic Burkitt lymphoma. PLoS Pathog., 11(10), e1005158 (2015).
   PubMed Web of Science ®Google Scholar